0.00
price down icon100.00%   -9.81
after-market 시간 외 거래: 10.10 10.10 +
loading

Allovir Inc 주식(ALVR)의 최신 뉴스

pulisher
Jun 05, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating AlloVir Inc. (ALVR) And Encourages Stockholders to Connect - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Bernstein Liebhard LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of AlloVir, Inc. Securities - TradingView

Jun 05, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Sells 251,018 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Wall Street Zen Upgrades Allovir (NASDAQ:KLRS) to Hold - MarketBeat

Jun 05, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Acquires New Holdings in AlloVir, Inc. (NASDAQ:ALVR) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

AlloVir Inc. (ALVR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 01, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AlloVir Inc. (ALVR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jun 01, 2025
pulisher
Jun 01, 2025

Allovir (NASDAQ:KLRS) Upgraded to “Hold” at Wall Street Zen - Defense World

Jun 01, 2025
pulisher
May 29, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages AlloVir Inc. (ALVR) Investors to Inquire about Securities Investigation - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Kalaris: Phase 1 Trial for TH103 Advances Following AlloVir Merger and Other Important Updates - TradingView

May 29, 2025
pulisher
May 26, 2025

Allovir (NASDAQ:KLRS) Rating Lowered to Sell at Wall Street Zen - Defense World

May 26, 2025
pulisher
May 19, 2025

Deadline to Claim Your Payout from the AlloVir $ALVR Settlement Is in 3 Months - TradingView

May 19, 2025
pulisher
May 14, 2025

AlloVir ($ALVR) Is Paying a Settlement to Investors — Here’s How to Get Your Share - TradingView

May 14, 2025
pulisher
May 14, 2025

Kalaris Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Kalaris Eyes Breakthrough in AMD Treatment: Phase 1 Trial Progress and $101M War Chest Revealed in Q1 Earnings - Stock Titan

May 14, 2025
pulisher
May 10, 2025

Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir LawsuitALVR - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

AlloVir, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your RightsALVR - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Lost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class ActionALVR - ACCESS Newswire

May 10, 2025
pulisher
May 07, 2025

Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineALVR - ACCESS Newswire

May 07, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Trims Stock Position in AlloVir, Inc. (NASDAQ:ALVR) - Defense World

May 07, 2025
pulisher
May 02, 2025

DEADLINE ALERT: Bernstein Liebhard LLP Reminds AlloVir, Inc. Investors of Upcoming Deadline - ACCESS Newswire

May 02, 2025
pulisher
Apr 28, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineALVR - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 28, 2025

Levi & Korsinsky Notifies AlloVir, Inc.(ALVR) Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com

Apr 28, 2025
pulisher
Apr 24, 2025

Halper Sadeh LLP, AlloVir, Inc., Avid Bioservices, Inc., EMCORE Corporation - The Bradford Era

Apr 24, 2025
pulisher
Apr 19, 2025

Halper Sadeh LLP, Aerovate Therapeutics, Inc., Staffing 360 Solutions, Inc., Allovir - The Bradford Era

Apr 19, 2025
pulisher
Apr 09, 2025

AlloVir Announces FDA Clearance of Investigational New Drug Application for ALVR106, an Allogeneic, Off-The-Shelf, Multi-Virus Specific T Cell Therapy Targeting Four Devastating Respiratory Viruses - marketscreener.com

Apr 09, 2025
pulisher
Apr 08, 2025

William Blair Initiates Kalaris Therapeutics With Outperform Rating - MarketScreener

Apr 08, 2025
pulisher
Apr 06, 2025

(ALVR) Technical Data - news.stocktradersdaily.com

Apr 06, 2025
pulisher
Apr 05, 2025

Kalaris Therapeutics appoints new board chair By Investing.com - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024(NASDAQ: ALVR) - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

Kalaris Therapeutics appoints new board chair - Investing.com India

Apr 04, 2025
pulisher
Apr 04, 2025

Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee - The Manila Times

Apr 04, 2025
pulisher
Apr 04, 2025

Kalaris Expands Board Of Directors Appointing Leone Patterson As Chair Of Audit Committee - MarketScreener

Apr 04, 2025
pulisher
Apr 03, 2025

Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 01, 2025

ALLOVIR INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options - MarketScreener

Apr 01, 2025
pulisher
Mar 31, 2025

ALVR Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - MarketScreener

Mar 31, 2025
pulisher
Mar 29, 2025

The Law Offices of Vincent Wong Remind AlloVir Investors of a Lead Plaintiff Deadline of March 19, 2024 - MarketScreener

Mar 29, 2025
pulisher
Mar 29, 2025

ROSEN, SKILLED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionALVR - MarketScreener

Mar 29, 2025
pulisher
Mar 29, 2025

ALLOVIR SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options - Marketscreener.com

Mar 29, 2025
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
자본화:     |  볼륨(24시간):